memantine has been researched along with Brain Vascular Disorders in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Assessing these factors, I discuss how treatable vascular dementia presently is." | 2.53 | [How Treatable is Vascular Dementia?]. ( Mori, E, 2016) |
| "Memantine has been used clinically in the treatment of Parkinson's disease and spasticity for a number of years." | 1.30 | Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat. ( Le, DA; Lipton, SA; Sathi, S; Stieg, PE; Warach, S, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamoto, K | 1 |
| Ikeda, K | 1 |
| Mizumura, S | 1 |
| Tachiki, K | 1 |
| Yanagihashi, M | 1 |
| Iwasaki, Y | 1 |
| Takahashi, H | 1 |
| Xia, P | 1 |
| Cui, J | 1 |
| Talantova, M | 1 |
| Bodhinathan, K | 1 |
| Li, W | 2 |
| Saleem, S | 1 |
| Holland, EA | 1 |
| Tong, G | 1 |
| Piña-Crespo, J | 1 |
| Zhang, D | 1 |
| Nakanishi, N | 1 |
| Larrick, JW | 1 |
| McKercher, SR | 1 |
| Nakamura, T | 1 |
| Wang, Y | 2 |
| Lipton, SA | 2 |
| Mori, E | 1 |
| Chen, B | 1 |
| Wang, G | 1 |
| Liu, W | 1 |
| Lin, R | 1 |
| Tao, J | 1 |
| Jiang, M | 1 |
| Chen, L | 1 |
| Gudkova, AA | 1 |
| Sorokina, IB | 1 |
| Iakovlev, AA | 1 |
| Guliaeva, NV | 1 |
| Gekht, AB | 1 |
| Mao, FX | 1 |
| Li, WJ | 1 |
| Chen, HJ | 1 |
| Qian, LH | 1 |
| Buzby, JS | 1 |
| Bowler, JV | 1 |
| Birks, J | 1 |
| Flicker, L | 1 |
| Stieg, PE | 1 |
| Sathi, S | 1 |
| Warach, S | 1 |
| Le, DA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study of Memantine for Enhanced Stroke Recovery[NCT02144584] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2014-01-31 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for memantine and Brain Vascular Disorders
| Article | Year |
|---|---|
[How Treatable is Vascular Dementia?].
Topics: Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition Disorders; Dementia, Vascular; Human | 2016 |
Investigational treatment for vascular cognitive impairment.
Topics: Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition Disorders; Dementia, Vascular; Drugs | 2007 |
1 trial available for memantine and Brain Vascular Disorders
| Article | Year |
|---|---|
[Akatinol memantine in patients with vascular cognitive disorders].
Topics: Aged; Aged, 80 and over; Cerebrovascular Disorders; Cognition; Cognition Disorders; Excitatory Amino | 2010 |
7 other studies available for memantine and Brain Vascular Disorders
| Article | Year |
|---|---|
Combined treatment of methylprednisolone pulse and memantine hydrochloride prompts recovery from neurological dysfunction and cerebral hypoperfusion in carbon monoxide poisoning: a case report.
Topics: Antiparkinson Agents; Carbon Monoxide Poisoning; Cerebrovascular Circulation; Cerebrovascular Disord | 2014 |
Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease.
Topics: Animals; Anura; Apoptosis; Brain Ischemia; Cerebrovascular Disorders; Long-Term Potentiation; Maze L | 2015 |
Memantine attenuates cell apoptosis by suppressing the calpain-caspase-3 pathway in an experimental model of ischemic stroke.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Brain Ischemia; Calpain; Caspase 3; Cerebral Arteries; C | 2017 |
Periventricular leukomalacia long-term prognosis may be improved by treatment with UDP-glucose, GDNF, and memantine in neonatal rats.
Topics: Animals; Animals, Newborn; Cerebral Ventricles; Cerebrovascular Disorders; Drug Therapy, Combination | 2012 |
Vascular cognitive impairment.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cerebrovascular Disorders; Cholinesterase Inhibito | 2004 |
Stroke, Alzheimer's patients may benefit from AIDS dementia drug.
Topics: AIDS Dementia Complex; Alzheimer Disease; Cerebrovascular Disorders; Clinical Trials as Topic; Excit | 1997 |
Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat.
Topics: Animals; Animals, Newborn; Brain; Brain Ischemia; Cerebrovascular Disorders; Disease Models, Animal; | 1999 |